Natalie Labouret-Hoog
Boulogne-billancourt, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMART.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 22, 2024
AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial.
Journal: Nature medicine
Published: October 19, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma.
Journal: ESMO open
Published: August 09, 2023
What should be done in terms of fertility preservation for patients with cancer? The French 2021 guidelines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 15, 2022
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Journal: Cancer discovery
Published: May 26, 2021
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 18, 2020
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 05, 2019
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report.
Journal: Journal of medical case reports
Published: May 03, 2019
Fertility preservation and cancer: How many persons are concerned?
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: January 25, 2018
Equal access to innovative therapies and precision cancer care.
Journal: Nature reviews. Clinical oncology
Published: March 23, 2016
Last Updated: 09/26/2026